BridgeBio Pharma Inc (BBIO)
25.25
+0.27
(+1.08%)
USD |
NASDAQ |
Apr 18, 13:45
BridgeBio Pharma Gross Profit Margin (Quarterly): 65.73% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 65.73% |
| September 30, 2023 | 85.38% |
| June 30, 2023 | 63.50% |
| March 31, 2023 | 64.35% |
| December 31, 2022 | 65.40% |
| September 30, 2022 | -118.6% |
| June 30, 2022 | 99.05% |
| March 31, 2022 | 20.42% |
| December 31, 2021 | 87.96% |
| Date | Value |
|---|---|
| September 30, 2021 | 37.97% |
| June 30, 2021 | 99.80% |
| March 31, 2021 | |
| December 31, 2020 | |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | 90.65% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-118.6%
Minimum
Sep 2022
99.80%
Maximum
Jun 2021
55.13%
Average
65.57%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 46.92% |
| Alnylam Pharmaceuticals Inc | 80.47% |
| Ardelyx Inc | 85.23% |
| Regenxbio Inc | 49.41% |
| IDEAYA Biosciences Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -108.9% |
| Return on Invested Capital | -143.4% |
| Profit Margin (Quarterly) | -9.64K% |
| Operating Margin (Quarterly) | -10.12K% |
| Return on Net Operating Assets | -1.09K% |